Exodus Point Capital Management, LP Cyclerion Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.56 - $2.99 $35,413 - $67,875	-22,701 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.13 $3,106 - $4,699	1,138 Added 5.28%	22,701 $70,000
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.29 $47,007 - $92,505	21,563 New	21,563 $84,000
Q4 2020 Feb 16, 2021	SELL	$2.25 - $7.12 $38,992 - $123,389	-17,330 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.46 - $8.39 $59,961 - $145,398	17,330 New	17,330 $105,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $113M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.